Certara, Inc.
HealthcareNASDAQ:CERT · NASDAQ Global Select
-$0.07 today
Vol 3.22M · Avg 3.99M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-0.2%
avg -2.6%
ROIC
-0.3%
avg -0.1%
ROA
-0.1%
avg -1.5%
Analysis
ROA is currently the strongest return metric at -0.1% versus its period average of -1.5%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Jon Resnick | Chief Executive Officer & Director | $1.40M | — | 53 | $740,740.00 | 0.48% |
Adrian K. McKemey | President of Drug Development Solutions | $1.08M | — | — | $21,698.00 | 0.01% |
John E. Gallagher | SVP, Principal Accounting Officer & Chief Financial Officer | $924,248.00 | — | 53 | $33,222.00 | 0.02% |
Robert Aspbury | President of Certara Predictive Technologies | $826,125.00 | — | 54 | $246,913.00 | 0.16% |
Leif E. Pedersen | President & Chief Commercial Officer | $690,082.00 | — | 61 | $111,111.00 | 0.07% |
Rona Anhalt | Chief Human Resources Officer | — | — | 61 | $19,030.00 | 0.01% |
Sheila Rocchio | Chief Marketing Officer | — | — | — | — | — |
Martin Snyder | President of Certara Data Sciences | — | — | — | — | — |
Christopher Bouton | Chief Technology Officer & Chief AI Officer | — | — | — | — | — |
Ron DiSantis | Senior Vice President of Corporate Development | — | — | — | — | — |
Daniel Corcoran | Senior Vice President, General Counsel & Secretary | — | — | 59 | $39,939.00 | 0.03% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$199,999.99
Sells
1
$559,366.08
Net Sentiment
$359,366.09
Net selling
Most Active
Feehery William F
1 transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Nov 11, 2025 | Feehery William F Direct | Buy | 24.1K | $8.30 | $199,999.99 | |
| Sep 9, 2025 | Pedersen Leif E Direct | Sell | 51.2K | $10.92 | $559,366.08 |
Analysis
Insiders reported 1 buys worth $199,999.99 and 1 sells worth $559,366.08 over the last 12 months. That adds up to net selling of $359,366.09. Feehery William F was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | +29.2% (7yr)1 analysts |
| Revenue | N/A | N/A | +17.2% | +4.5% (7yr)3 analysts |
| Net Income | N/A | N/A | N/A | +29.3% (7yr)3 analysts |
| EBIT | N/A | N/A | +18.4% | -12.3% (7yr)3 analysts |
Analysis
Recent growth has been strongest in EBIT at +18.4% over three years. Forward estimates point to Net Income at +29.3% (7yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Twist Bioscience Corporation
NASDAQ:TWST
$4.74B
10x Genomics, Inc.
NASDAQ:TXG
$3.66B
National HealthCare Corporation
AMEX:NHC
$3.09B
Clover Health Investments, Corp.
NASDAQ:CLOV
$2.45B
Progyny, Inc.
NASDAQ:PGNY
$2.09B
Vericel Corporation
NASDAQ:VCEL
$1.91B
Omnicell, Inc.
NASDAQ:OMCL
$1.72B
Aveanna Healthcare Holdings Inc.
NASDAQ:AVAH
$1.54B
Schrödinger, Inc.
NASDAQ:SDGR
$1.08B
QuidelOrtho Corporation
NASDAQ:QDEL
$963.54M
Who manages CERT?
Certara, Inc. (CERT) lists 11 active executives. The top listed executive is Robert Aspbury, President of Certara Predictive Technologies.
Are CERT insiders buying or selling?
Recent insider activity shows net selling of $2.06M.
Explore More
Continue the stock analysis
Jump to another research area for this company.